| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2007PLoSO...2..873H |
| P356 | DOI | 10.1371/JOURNAL.PONE.0000873 |
| P932 | PMC publication ID | 1964806 |
| P698 | PubMed publication ID | 17849003 |
| P5875 | ResearchGate publication ID | 5991535 |
| P50 | author | Ingrid Agartz | Q28050104 |
| Thomas Werge | Q29122092 | ||
| Ingrid Melle | Q47083123 | ||
| Ole A. Andreassen | Q31229142 | ||
| Srdjan Djurovic | Q34568432 | ||
| Thomas F. Hansen | Q37651587 | ||
| Henrik Ullum | Q40974711 | ||
| Erik G Jönsson | Q43004484 | ||
| P2093 | author name string | August G Wang | |
| Håkan Hall | |||
| Morten Lindow | |||
| Line Olsen | |||
| Klaus D Jakobsen | |||
| Sally Timm | |||
| P2860 | cites work | microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder | Q21184126 |
| Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation | Q21194851 | ||
| Human MicroRNA targets | Q21563637 | ||
| Reliability of clinical ICD-10 schizophrenia diagnoses | Q22248044 | ||
| Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 | ||
| A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis | Q24537628 | ||
| Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls | Q24550675 | ||
| Identification of many microRNAs that copurify with polyribosomes in mammalian neurons | Q24630366 | ||
| PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
| Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies | Q26734731 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Haploview: analysis and visualization of LD and haplotype maps | Q27860955 | ||
| Large-scale transcriptional activity in chromosomes 21 and 22 | Q28216457 | ||
| Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution | Q28241731 | ||
| Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress | Q28257571 | ||
| Microarray analysis of postmortem temporal cortex from patients with schizophrenia | Q80502608 | ||
| Diagnostic agreement of schizophrenia spectrum disorders among chronic patients with functional psychoses | Q43869768 | ||
| Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study | Q44344393 | ||
| Characterization of patients with schizophrenia and related psychoses: evaluation of different diagnostic procedures | Q44474111 | ||
| Highly parallel SNP genotyping | Q46226424 | ||
| Dicer and eIF2c are enriched at postsynaptic densities in adult mouse brain and are modified by neuronal activity in a calpain-dependent manner | Q46644002 | ||
| Small RNAs in human brain development and disorders | Q48685763 | ||
| Pedigree disequilibrium tests for multilocus haplotypes. | Q52010978 | ||
| Genomics: The amazing complexity of the human transcriptome | Q57020007 | ||
| Evidence for the multigenic inheritance of schizophrenia | Q57400481 | ||
| The widespread impact of mammalian MicroRNAs on mRNA repression and evolution | Q29547173 | ||
| Control of translation and mRNA degradation by miRNAs and siRNAs | Q29614239 | ||
| A brain-specific microRNA regulates dendritic spine development | Q29614753 | ||
| A microRNA controlling left/right neuronal asymmetry in Caenorhabditis elegans | Q29616578 | ||
| Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia | Q29618963 | ||
| The neuropathology of schizophrenia. A critical review of the data and their interpretation | Q30573678 | ||
| The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains | Q33878357 | ||
| The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications | Q33979202 | ||
| MicroRNAs act sequentially and asymmetrically to control chemosensory laterality in the nematode. | Q34340657 | ||
| Reciprocal actions of REST and a microRNA promote neuronal identity | Q34479303 | ||
| Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism | Q35677795 | ||
| Phenotype of schizophrenia: a review and formulation | Q35875976 | ||
| Expanding the 'central dogma': the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia | Q35894474 | ||
| Neurodevelopment, neuroplasticity, and new genes for schizophrenia | Q35974517 | ||
| Non-coding RNAs in the nervous system | Q36523588 | ||
| Specific microRNAs modulate embryonic stem cell-derived neurogenesis. | Q37020782 | ||
| Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses | Q40368967 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| microRNA | Q310899 | ||
| P304 | page(s) | e873 | |
| P577 | publication date | 2007-09-12 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Brain expressed microRNAs implicated in schizophrenia etiology | |
| P478 | volume | 2 |
| Q34813357 | A Computational Approach for Predicting Role of Human MicroRNAs in MERS-CoV Genome. |
| Q35156184 | A new polymorphism biomarker rs629367 associated with increased risk and poor survival of gastric cancer in chinese by up-regulated miRNA-let-7a expression |
| Q33531348 | A novel microRNA and transcription factor mediated regulatory network in schizophrenia |
| Q33710067 | A potential role for intragenic miRNAs on their hosts' interactome. |
| Q53617987 | A preliminary analysis of microRNA as potential clinical biomarker for schizophrenia. |
| Q37180715 | Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis |
| Q37295063 | Advances in microRNAs: implications for immunity and inflammatory diseases |
| Q36480165 | Association between a genetic variant in the serotonin transporter gene (SLC6A4) and suicidal behavior in patients with schizophrenia |
| Q43278134 | Association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age of onset in schizophrenia |
| Q48126921 | Association between two single nucleotide polymorphisms at corresponding microRNA and schizophrenia in a Chinese population. |
| Q48590709 | Association of the leucine-7 to proline-7 variation in the signal sequence of neuropeptide Y with major depression |
| Q34458640 | Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysis |
| Q36660448 | Big effects of small RNAs: a review of microRNAs in anxiety |
| Q36955877 | Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis. |
| Q42604971 | Brain banking: opportunities, challenges and meaning for the future |
| Q34110230 | Brain derived neurotrophic factor (BDNF) expression is regulated by microRNAs miR-26a and miR-26b allele-specific binding. |
| Q38189850 | Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. |
| Q39735837 | C-T variant in a miRNA target site of BCL2 is associated with increased risk of human papilloma virus related cervical cancer--an in silico approach |
| Q24633405 | CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells |
| Q34150000 | Catalog of microRNA seed polymorphisms in vertebrates |
| Q34426839 | Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy |
| Q36592619 | Cerebralcare Granule® attenuates cognitive impairment in rats continuously overexpressing microRNA-30e |
| Q28308288 | Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer |
| Q41958415 | Chronic intermittent ethanol exposure and its removal induce a different miRNA expression pattern in primary cortical neuronal cultures |
| Q34683670 | Chronological changes in microRNA expression in the developing human brain |
| Q30982356 | Circulating miRNAs profiles in Tourette syndrome: molecular data and clinical implications. |
| Q38103194 | Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases |
| Q48215851 | Common and rare variants of microRNA genes in autism spectrum disorders |
| Q26824150 | Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome |
| Q31059827 | DCLK1 variants are associated across schizophrenia and attention deficit/hyperactivity disorder |
| Q33863288 | Deep sequencing analysis of the developing mouse brain reveals a novel microRNA |
| Q38806729 | Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future. |
| Q61814979 | Differential regulation of brain-derived neurotrophic factor (BDNF) expression in sensory neuron axons by miRNA-206 |
| Q40026960 | Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. |
| Q50419804 | Dysregulation of miRNA and its potential therapeutic application in schizophrenia. |
| Q92493187 | Dysregulation of microRNA metabolism in motor neuron diseases: Novel biomarkers and potential therapeutics |
| Q43080651 | Effect of Propofol on microRNA Expression Profile in Adipocyte-Derived Adult Stem Cells |
| Q43677691 | Evaluation of six SNPs of MicroRNA machinery genes and risk of schizophrenia |
| Q33924728 | Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137. |
| Q36837420 | Expression quantitative trait loci (eQTLs) in microRNA genes are enriched for schizophrenia and bipolar disorder association signals |
| Q35898733 | Gender-Specific Reduction of Estrogen-Sensitive Small RNA, miR-30b, in Subjects With Schizophrenia |
| Q37593741 | Genetic variation in the miR-708 gene and its binding targets in bipolar disorder. |
| Q34023060 | Genome-wide association study identifies four loci associated with eruption of permanent teeth |
| Q50603583 | Hairless Up-Regulates Tgf-β2 Expression via Down-Regulation of miR-31 in the Skin of "Hairpoor" (HrHp) Mice |
| Q34447816 | Heterogeneity and individuality: microRNAs in mental disorders |
| Q33812139 | Identification of putative pathogenic SNPs implied in schizophrenia-associated miRNAs |
| Q36082773 | Immunopathologic processes in sympathetic ophthalmia as signified by microRNA profiling |
| Q28651637 | Improving miRNA-mRNA interaction predictions |
| Q57804003 | Innate immune activation of astrocytes impairs neurodevelopment via upregulation of follistatin-like 1 and interferon-induced transmembrane protein 3 |
| Q91229528 | Intracellular compartment-specific proteasome dysfunction in postmortem cortex in schizophrenia subjects |
| Q37451886 | Long-term effects of peripubertal binge EtOH exposure on hippocampal microRNA expression in the rat |
| Q37083847 | Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age at onset of schizophrenia: no consistent evidence for an association in the Nordic population |
| Q34245074 | MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis |
| Q48496276 | MiRNA profile in the substantia nigra of Parkinson's disease and healthy subjects. |
| Q21129476 | Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders |
| Q38235947 | MicroRNA and Male Infertility: A Potential for Diagnosis |
| Q37992401 | MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction |
| Q24630375 | MicroRNA dysregulation in psychiatric disease |
| Q35550957 | MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment |
| Q34200641 | MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects |
| Q35216295 | MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders |
| Q33344502 | MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression |
| Q37741192 | MicroRNA signatures in neurological disorders |
| Q33553774 | MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation |
| Q27321524 | MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis |
| Q37511094 | MicroRNA-206: a promising theranostic marker. |
| Q37125050 | MicroRNA-206: the skeletal muscle-specific myomiR. |
| Q24644849 | MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction |
| Q36139699 | MicroRNA-derived network analysis of differentially methylated genes in schizophrenia, implicating GABA receptor B1 [GABBR1] and protein kinase B [AKT1] |
| Q34100916 | MicroRNA-mediated gene regulation plays a minor role in the transcriptomic plasticity of cold-acclimated zebrafish brain tissue |
| Q42004179 | MicroRNA: Biogenesis, Function and Role in Cancer |
| Q24652987 | MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders |
| Q35009094 | MicroRNAs as a target for novel antipsychotics: a systematic review of an emerging field. |
| Q38272668 | MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis |
| Q35624533 | MicroRNAs in Human Diseases: From Autoimmune Diseases to Skin, Psychiatric and Neurodegenerative Diseases |
| Q38843644 | MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments? |
| Q88111994 | MicroRNAs in Parkinson's disease |
| Q38267957 | MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective. |
| Q37368965 | MicroRNAs in mental health: from biological underpinnings to potential therapies |
| Q36589809 | MicroRNAs in neuronal function and dysfunction |
| Q37730250 | MicroRNAs in psychiatric and neurodevelopmental disorders |
| Q21142742 | MicroRNAs show mutually exclusive expression patterns in the brain of adult male rats |
| Q64226456 | MicroRNAs: Recent insights towards their role in male infertility and reproductive cancers |
| Q38027374 | MicroRNAs: a light into the "black box" of neuropediatric diseases? |
| Q42270340 | MicroRNAs: fundamental regulators of gene expression in major affective disorders and suicidal behavior? |
| Q37141220 | MicroRNAs: novel regulators in skin inflammation |
| Q38066958 | Modeling schizophrenia: uncovering novel therapeutic targets. |
| Q34855154 | Monoallelic deletion of the microRNA biogenesis gene Dgcr8 produces deficits in the development of excitatory synaptic transmission in the prefrontal cortex |
| Q52320951 | Non-Coding RNA as Novel Players in the Pathophysiology of Schizophrenia. |
| Q33498938 | Nuclear receptor SHP activates miR-206 expression via a cascade dual inhibitory mechanism |
| Q102210879 | PCM1 is necessary for focal ciliary integrity and is a candidate for severe schizophrenia |
| Q33601105 | Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates |
| Q33673025 | Pharmacology of epigenetics in brain disorders |
| Q46308032 | Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples |
| Q39912712 | SCAN: a systems biology approach to pharmacogenomic discovery |
| Q37559492 | Searching genetic risk factors for schizophrenia and bipolar disorder: learn from the past and back to the future |
| Q29013737 | Sequence Relationships among C. elegans, D. melanogaster and Human microRNAs Highlight the Extensive Conservation of microRNAs in Biology |
| Q37134134 | Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics |
| Q33836761 | Temporal differences in microRNA expression patterns in astrocytes and neurons after ischemic injury |
| Q28112165 | The Emerging Role of microRNAs in Schizophrenia and Autism Spectrum Disorders |
| Q64987362 | The Relationship between Gene Polymorphism of miRNAs Regulating FGA and Schizophrenia. |
| Q21562295 | The effect of central loops in miRNA:MRE duplexes on the efficiency of miRNA-mediated gene regulation |
| Q37784878 | The role of microRNAs in drug addiction: a big lesson from tiny molecules |
| Q37519468 | The tryptophan hydroxylase 1 (TPH1) gene, schizophrenia susceptibility, and suicidal behavior: a multi-centre case-control study and meta-analysis |
| Q37231802 | Thinking about RNA? MicroRNAs in the brain |
| Q43845557 | Topological properties of the drug targets regulated by microRNA in human protein–protein interaction network |
| Q27863407 | Tubulin polymerization-promoting protein (TPPP/p25) is critical for oligodendrocyte differentiation |
| Q52316311 | Validation of a microRNA target site polymorphism in H3F3B that is potentially associated with a broad schizophrenia phenotype. |
| Q38129463 | When less is more--microRNAs and psychiatric disorders. |
| Q33400321 | miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1 |
| Q48397272 | miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model |
| Q37622916 | miRNA and neurons |
| Q37781312 | miRNA genes and the brain: implications for psychiatric disorders. |
| Q37707755 | miRNAs and their role in the correlation between schizophrenia and cancer (Review). |
| Q37490887 | microRNA regulation of synaptic plasticity |
| Q38265172 | microRNAs as novel biomarkers of schizophrenia (Review) |
| Q38472671 | microRNAs in CNS disorders |
| Q47564833 | microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches. |
| Q37215293 | microRNAs: tiny regulators of synapse function in development and disease |
Search more.